Cargando…
De-Escalating Anti-Pseudomonal β-Lactams
Autores principales: | Catteeuw, J, De Bus, L, Denys, W, Gadeyne, B, De Waele, JJ, Decruyenaere, J, Depuydt, PO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798580/ http://dx.doi.org/10.1186/2197-425X-3-S1-A3 |
Ejemplares similares
-
Outcomes of adult patients in the intensive care unit with Pseudomonas
aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?
por: Lodise, Thomas P., et al.
Publicado: (2021) -
A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration
por: De Bus, Liesbet, et al.
Publicado: (2018) -
1883. Acute Kidney Injury in Patients With Pneumonia on Concomitant Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonal β-Lactam Therapy
por: Raux, Brian R, et al.
Publicado: (2018) -
Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis
por: De Bus, Liesbet, et al.
Publicado: (2014) -
239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020)